Analysis of All-Cause Hospitalization and Death Among Nonhospitalized Patients With Type 2 Diabetes and SARS-CoV-2 Infection Treated With Molnupiravir or Nirmatrelvir-Ritonavir During the Omicron Wave in Hong Kong
Sign Up to like & getrecommendations! Published in 2023 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2023.14393
Abstract: Key Points Question Are oral antiviral medications such as molnupiravir and nirmatrelvir-ritonavir associated with improved outcomes among patients with type 2 diabetes and COVID-19? Findings In this cohort study of 22 098 patients in Hong Kong… read more here.
Keywords: cause; nirmatrelvir ritonavir; type diabetes; hospitalization ... See more keywords
Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concern
Sign Up to like & getrecommendations! Published in 2022 at "Antiviral Research"
DOI: 10.1016/j.antiviral.2022.105252
Abstract: We assessed the in vitro antiviral activity of remdesivir and its parent nucleoside GS-441524, molnupiravir and its parent nucleoside EIDD-1931 and the viral protease inhibitor nirmatrelvir against the ancestral SARS-CoV2 strain and the five variants… read more here.
Keywords: concern; molnupiravir nirmatrelvir; nirmatrelvir remain; variants concern ... See more keywords
New Perspectives on Antimicrobial Agents: Molnupiravir and Nirmatrelvir/Ritonavir for Treatment of COVID-19
Sign Up to like & getrecommendations! Published in 2022 at "Antimicrobial Agents and Chemotherapy"
DOI: 10.1128/aac.02404-21
Abstract: Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has emerged to cause pandemic respiratory disease in the past 2 years, leading to significant worldwide morbidity and mortality. At the beginning of the pandemic, only nonspecific treatments were… read more here.
Keywords: nirmatrelvir ritonavir; treatment; respiratory; molnupiravir nirmatrelvir ... See more keywords